Get the Stockscreener App
13.55
4.04%
-0.57
Beta Bionics Inc stock is traded at $13.55, with a volume of 543.77K.
It is down -4.04% in the last 24 hours and down -23.23% over the past month.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
See More
Previous Close:
$14.12
Open:
$14.42
24h Volume:
543.77K
Relative Volume:
0.53
Market Cap:
$596.53M
Revenue:
$78.02M
Net Income/Loss:
$-73.37M
P/E Ratio:
-10.27
EPS:
-1.32
Net Cash Flow:
$-62.06M
1W Performance:
+2.34%
1M Performance:
-23.23%
6M Performance:
-4.71%
1Y Performance:
-38.38%
1-Day Range:
$13.53
$14.74
1-Week Range:
$12.71
$15.53
52-Week Range:
$8.89
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Name
Beta Bionics Inc
Sector
Industry
Phone
949-427-7785
Address
11 HUGHES, IRVINE
Compare BBNX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
13.55 | 621.63M | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Initiated | UBS | Buy |
| Jan-27-26 | Initiated | TD Cowen | Hold |
| Jan-09-26 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-21-25 | Resumed | Stifel | Buy |
| Oct-01-25 | Upgrade | Goldman | Neutral → Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| Jun-12-25 | Initiated | Lake Street | Buy |
| May-30-25 | Initiated | Goldman | Neutral |
| May-30-25 | Initiated | Wolfe Research | Outperform |
| Feb-24-25 | Initiated | BofA Securities | Buy |
| Feb-24-25 | Initiated | Lake Street | Buy |
| Feb-24-25 | Initiated | Leerink Partners | Outperform |
| Feb-24-25 | Initiated | Piper Sandler | Overweight |
| Feb-24-25 | Initiated | Stifel | Buy |
| Feb-20-25 | Initiated | Ladenburg Thalmann | Neutral |
| Feb-20-25 | Initiated | Robert W. Baird | Neutral |
View All
Beta Bionics Inc Stock (BBNX) Latest News
UBS Group Upgrades Beta Bionics (NASDAQ:BBNX) to "Strong-Buy" - MarketBeat
Beta Bionics (NASDAQ:BBNX) Trading Up 7.9%Here's What Happened - MarketBeat
Will Beta Bionics, Inc. (BBNX) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Essex Investment Management Co. LLC Takes Position in Beta Bionics, Inc. $BBNX - MarketBeat
Beta Bionics (NASDAQ:BBNX) Shares Gap UpTime to Buy? - MarketBeat
Resistance Check: How liquid is Beta Bionics Inc stockSwing Trade & Real-Time Chart Pattern Alerts - baoquankhu1.vn
UBS Initiates Coverage on Beta Bionics With Buy Rating, $24 Price Target - marketscreener.com
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
UBS initiates coverage on Beta Bionics stock with Buy rating By Investing.com - Investing.com Nigeria
UBS initiates coverage on Beta Bionics stock with Buy rating - Investing.com
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Beh - GuruFocus
INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - PR Newswire
Faruqi & Faruqi Investigates Aquestive Therapeutics for Investor Losses - intellectia.ai
Beta Bionics, Inc.'s (NASDAQ:BBNX) Popularity With Investors Under Threat As Stock Sinks 58% - simplywall.st
Artificial Pancreas System Market is expected to reach US$ - openPR.com
Stifel Nicolaus Lowers Beta Bionics (NASDAQ:BBNX) Price Target to $25.00 - MarketBeat
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Beta Bionics, Inc.BBNX - Chartmill
Beta Bionics receives FDA warning letter - MedTech Dive
TD Cowen reiterates Hold rating on Beta Bionics stock amid FDA warning letter - Investing.com Australia
TD Cowen reiterates Hold rating on Beta Bionics stock amid FDA warning letter By Investing.com - Investing.com South Africa
Beta Bionics stock holds steady as TD Cowen reiterates $17 price target By Investing.com - Investing.com South Africa
Beta Bionics stock holds steady as TD Cowen reiterates $17 price target - Investing.com Canada
Truist Financial Has Lowered Expectations for Beta Bionics (NASDAQ:BBNX) Stock Price - MarketBeat
Balanced Risk-Reward Amid FDA Warning Letter Keeps Beta Bionics at Hold - TipRanks
Truist Securities lowers Beta Bionics stock price target to $25 from $37 By Investing.com - Investing.com South Africa
Truist Securities lowers Beta Bionics stock price target to $25 from $37 - Investing.com Nigeria
Truist Trims Price Target on Beta Bionics to $25 From $37, Keeps Buy Rating - marketscreener.com
Beta Bionics, Inc. (NASDAQ:BBNX) Short Interest Down 24.0% in January - MarketBeat
Beta Bionics Receives FDA Warning Letter, Begins Remediation - TipRanks
Beta Bionics Receives FDA Warning Letter - TradingView
FDA warning letter hits Beta Bionics (NASDAQ: BBNX) but Mint plan stands - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc.AQST - PR Newswire
Aug Volume: Will Beta Bionics Inc stock benefit from M AEarnings Overview Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall ... - Caledonian Record
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Beta Bionics, Inc. (BBNX) And Encourages Shareholders to Connect - accessnewswire.com
Beta Bionics stock initiated with Hold rating at TD Cowen By Investing.com - Investing.com Nigeria
TD Cowen Initiates Coverage of Beta Bionics (BBNX) with Hold Recommendation - Nasdaq
Today's Analyst Rating: BBNX Receives 'Hold' Rating from TD Cowe - GuruFocus
Beyond The Numbers: 4 Analysts Discuss Beta Bionics Stock - Benzinga
Beta Bionics posts strong results in inaugural public company year - BioWorld MedTech
Beta Bionics stock initiated with Hold rating at TD Cowen - Investing.com
TD Cowen Initiates Beta Bionics at Hold WIth Price Target $17 - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Beta Bionics, Inc. (BBNX) And Encourages Shareholders to Reach Out - ACCESS Newswire
Beta Bionics Inc Stock (BBNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):